US Senate Advances BIOSECURE Legislation As China Biotech Security Heats Up

The US Senate moves closer to new legislation that would restrict Chinese "biotech companies of concern” from operating in the US, potentially causing broad and far-reaching impact.

Tension between the U.S. and china
US BIOSECURE Act would cast broad and wide restrictions on "biotech companies of concern" • Source: Shutterstock

On 6 March, the US Senate Committee on Homeland Security and Government Affairs voted in favor of advancing a bill restricting US government contracts and grants for services provided by “companies of concern,” as US congressional delegates from both sides of the aisle move to limit what is seen as growing Chinese influence in the country.

More from China

More from Asia